Randomized Study of the ICCAN Program Compared to Standard Hospital Services for Cancer Treatment Completion and Quality of Life

What this Trial Is About

This research aims to evaluate whether the Integrated Cancer Care Access Network ICCAN program improves cancer treatment completion and quality of life compared to standard hospital services like meeting with a Social Worker or Patient Navigator. The study focuses on cancer patients receiving chemotherapy or radiation therapy, including those from Black, Hispanic, and low socioeconomic status groups in New York City. It involves both observational and behavioral components to understand the impact of ICCAN on patient outcomes. Participants are assigned to one of two groups one receiving usual care with written materials on social and economic resources and standard referrals, and the other receiving the ICCAN program, which includes the same referrals plus monthly follow-ups with an ICCAN Access Facilitator to assist with ongoing social and economic needs. Both groups complete treatment outcomes surveys and have medical chart reviews at intake, 3 months, 6 months, and 1 year. During the study, participants complete surveys and undergo chart reviews to assess treatment adherence over one year and quality of life at various timepoints. The research team monitors ongoing social and economic needs and provides assistance as needed. The total participation duration includes at least one year of follow-up to evaluate primary and secondary outcomes related to treatment completion and quality of life.

Impact of ICCAN on Cancer Treatment Completion and Quality of Life